Getting muscles moving again after botulinum toxin: novel therapeutic challenges.
about
Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neuronsFlux of signalling endosomes undergoing axonal retrograde transport is encoded by presynaptic activity and TrkBSecond generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malariaPharmacophore Refinement Guides the Rational Design of Nanomolar-Range Inhibitors of the Botulinum Neurotoxin Serotype A MetalloproteaseA chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus.Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulismCargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: extending towards the β-exositeThe synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease.Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type aRecovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin AIdentification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype ARe-assembled botulinum neurotoxin inhibits CNS functions without systemic toxicity.GDNF overexpression fails to provoke muscle recovery from botulinum toxin poisoning: a preliminary study.Investigating novel therapeutic targets and molecular mechanisms to treat botulinum neurotoxin A intoxication.Glycine insertion at protease cleavage site of SNAP25 resists cleavage but enhances affinity for botulinum neurotoxin serotype A.Recombinant botulinum neurotoxin A heavy chain-based delivery vehicles for neuronal cell targeting.A Cell Line for Detection of Botulinum Neurotoxin Type B.Arachidonic acid potentiates exocytosis and allows neuronal SNARE complex to interact with Munc18a.The Effect of Botulinum Neurotoxin Serotype a Heavy Chain on the Growth Related Proteins and Neurite Outgrowth after Spinal Cord Injury in Rats.A role for SNAREs in neuronal survival?Glycerotoxin stimulates neurotransmitter release from N-type Ca2+ channel expressing neurons
P2860
Q27339199-7759432D-3454-49E2-9BA7-ACECADC09A29Q30849039-C8D29F89-5075-482A-8710-48E29C5C45E8Q33654562-F665DA5A-093E-4CC9-A149-4EBC1F38CA9FQ34353299-8E6F1386-6DE1-4D20-A0D1-48FE8BE58F5AQ34665879-7000C30D-3DAA-43B9-9598-B888580B099FQ34978565-E16A0FEA-7BE0-40C2-A007-6EA4AB498669Q35371760-43ED6FD1-B581-40ED-9F87-4DF74A2C7DC1Q35542237-BB0496AD-EBE6-40E0-806C-6C43ED6D31F6Q35681903-B928E09D-3355-4F2E-97FF-2DD85FA48F35Q35962427-EB4BE6A3-79D7-4F16-8476-6E5EB033DB3EQ35992376-EE2A600D-E4B5-45B4-B287-4DF09680C394Q36675606-1154755C-1CB0-4328-9A2A-C3AB84347C28Q36882760-6C3AD20C-2788-4290-AE83-EBA6CBF80DD0Q37274652-2C95C2C3-5F91-4B65-8B89-27A69386FA93Q38843144-1B8EC3B0-9B59-42AC-8FA4-590D4C71D7A5Q39369774-E57E8F21-CBAE-4761-BB9D-51BF2FB42E17Q40149882-558540B0-7B5E-4974-932F-6165C146C600Q41789006-1AD31BE2-75DD-42AA-A3B5-53B723C975AFQ42600051-3E08FBE7-9C78-4121-AA81-2F91A22E8A00Q47151324-7BDA3F3A-23A1-4B04-B5BF-0DD98CA254DDQ48332407-FE35029A-26D2-4B75-B939-45777A72C836Q49375875-B0AFA456-D457-4776-95E4-F10D2629DFB7Q58120572-B2907B1E-3266-4241-9E77-5BFB995FFAACQ58120721-7DDC7A70-576E-43D2-B2DA-2D3F4AA512D4
P2860
Getting muscles moving again after botulinum toxin: novel therapeutic challenges.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Getting muscles moving again after botulinum toxin: novel therapeutic challenges.
@ast
Getting muscles moving again after botulinum toxin: novel therapeutic challenges.
@en
type
label
Getting muscles moving again after botulinum toxin: novel therapeutic challenges.
@ast
Getting muscles moving again after botulinum toxin: novel therapeutic challenges.
@en
prefLabel
Getting muscles moving again after botulinum toxin: novel therapeutic challenges.
@ast
Getting muscles moving again after botulinum toxin: novel therapeutic challenges.
@en
P1476
Getting muscles moving again after botulinum toxin: novel therapeutic challenges.
@en
P2093
Bazbek Davletov
Patrick G Foran
P304
P356
10.1016/S1471-4914(03)00113-8
P577
2003-07-01T00:00:00Z